SeaStar Medical
About: SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
Employees: 12
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
2.69% less ownership
Funds ownership: 5.95% [Q2] → 3.26% (-2.69%) [Q3]
12% less funds holding
Funds holding: 17 [Q2] → 15 (-2) [Q3]
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
53% less capital invested
Capital invested by funds: $1.25M [Q2] → $584K (-$668K) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for ICU.
Financial journalist opinion
Based on 5 articles about ICU published over the past 30 days